- Home
- ETON vs HIFS Comparison
ETON vs HIFS Comparison
Compare ETON & HIFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- HIFS
- Stock Information
- Founded
- ETON 2017
- HIFS 1834
- Country
- ETON United States
- HIFS United States
- Employees
- ETON 31
- HIFS N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- HIFS Major Banks
- Sector
- ETON Health Care
- HIFS Finance
- Exchange
- ETON Nasdaq
- HIFS Nasdaq
- Market Cap
- ETON 498.8M
- HIFS 598.4M
- IPO Year
- ETON 2018
- HIFS N/A
- Fundamental
- Price
- ETON $18.25
- HIFS $294.07
- Analyst Decision
- ETON Strong Buy
- HIFS
- Analyst Count
- ETON 3
- HIFS 0
- Target Price
- ETON $29.67
- HIFS N/A
- AVG Volume (30 Days)
- ETON 261.2K
- HIFS 110.9K
- Earning Date
- ETON 11-06-2025
- HIFS 10-10-2025
- Dividend Yield
- ETON N/A
- HIFS 0.88%
- EPS Growth
- ETON N/A
- HIFS 94.74
- EPS
- ETON N/A
- HIFS 20.54
- Revenue
- ETON $58,181,000.00
- HIFS $90,528,000.00
- Revenue This Year
- ETON $105.25
- HIFS N/A
- Revenue Next Year
- ETON $40.84
- HIFS N/A
- P/E Ratio
- ETON N/A
- HIFS $13.97
- Revenue Growth
- ETON 85.40
- HIFS 54.99
- 52 Week Low
- ETON $8.24
- HIFS $209.71
- 52 Week High
- ETON $23.00
- HIFS $320.00
- Technical
- Relative Strength Index (RSI)
- ETON 46.28
- HIFS 51.34
- Support Level
- ETON $18.00
- HIFS $248.53
- Resistance Level
- ETON $18.92
- HIFS $320.00
- Average True Range (ATR)
- ETON 0.87
- HIFS 18.60
- MACD
- ETON -0.12
- HIFS 1.32
- Stochastic Oscillator
- ETON 40.66
- HIFS 53.84
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About HIFS Hingham Institution for Savings
Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.